Ezetimibe; Rosuvastatin Calcium Patent Expiration

Ezetimibe; Rosuvastatin Calcium is Used for lowering high levels of lipids in the blood. It was first introduced by Althera Pharmaceuticals Llc in its drug Roszet on Mar 23, 2021.


Ezetimibe; Rosuvastatin Calcium Patents

Given below is the list of patents protecting Ezetimibe; Rosuvastatin Calcium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Roszet US10376470 Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases May 01, 2033 Althera Pharms
Roszet US9763885 Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases May 01, 2033 Althera Pharms


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ezetimibe; Rosuvastatin Calcium's patents.

Given below is the list recent legal activities going on the following patents of Ezetimibe; Rosuvastatin Calcium.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 13 Feb, 2023 US10376470
Change in Power of Attorney (May Include Associate POA) 08 Oct, 2021 US9763885
Email Notification 08 Oct, 2021 US9763885
Change in Power of Attorney (May Include Associate POA) 08 Oct, 2021 US10376470
Email Notification 08 Oct, 2021 US10376470
Correspondence Address Change 06 Oct, 2021 US10376470
Payment of Maintenance Fee, 4th Yr, Small Entity 23 Nov, 2020 US9763885
Patent Issue Date Used in PTA Calculation 13 Aug, 2019 US10376470
Recordation of Patent Grant Mailed 13 Aug, 2019 US10376470
Email Notification 25 Jul, 2019 US10376470



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳